Back to results
US 2019/0298720 A1Published application
Use of src family kinase inhibitor in ribosomal disorder
AssigneeBioxcel Corporation
InventorKrishnan NANDABALAN
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods and compositions for the use of a Src family kinase (SFK) inhibitor for the treatment of anemia associated with ribosomal disorders, such as diamond blackfan anemia.
Claims20
A method of increasing or stimulating erythropoiesis in a subject suffering from anemia associated with a ribosomal disorder comprising administering to said subject an effective amount of a Src family kinase (SFK) inhibitor.
A method of treating a subject suffering from anemia associated with a ribosomal disorder, wherein the method comprises administering to the subject an effective amount of a SFK inhibitor.
Dependencies are inferred from the claim text.